To access this material please log in or register

Register Authorize

Management of patients with non-ST segment elevation acute coronary syndrome. Are all problems solved?

Barbarash O. L., Kashtalap V. V.
Federal State Budgetary Institution "Research Institute for Complex Issues of Cardiovascular Diseases", Federal Agency for Scientific Organizations, Sosnovy Bulvar 6, Kemerovo 650002

Keywords: ACS, conservative treatment, transcutaneous coronary intervention, cardiovascular risk

DOI: 10.18087/rhj.2016.5.2249

Based on data from relevant clinical studies, analysis of current recommendations on management of patients, and results of registry protocols, this review presents different aspects of managing patients with acute coronary syndrome (ACS) without stable ST segment elevation on the ECG (NSTE ACS), highlights unsolved issues of adequate evaluation and risk management for ischemic events following ACS, and defines prospective directions for further studies of these issues. This review was written using available materials from Russian and international databases (RINTS, Library’s MEDLINE / PubMed database).
  1.  50 Top Cardiovascular Hospitals Study Overview, 2016. 17th Edition. – Ann Arbour: 2015 Truven Health Analytics Inc. – 2015, November 9. – 40 p.
  2.   Tegn N, Abdelnoor M, Aaberge L, Endresen K, Smith P, Aakhus S et al. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial. Lancet. 2016 Mar 12;387 (10023):1057–65.
  3.   Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016 Jan 14;37 (3):267–315.
  4.   Бернс С. А., Зыкова Д. С., Шмидт Е. А., Юхно Е. С., Чувичкина О. В., Зыков М. В., Барбараш О. Л. Клиническая и прогностическая значимость мультифокального атеросклероза у больных с острым коронарным синдромом без подъема сегмента ST. Кардиология. 2012;52 (7):4–8 [Berns S. A., Zy`kova D. S., Shmidt E. A., Yuxno E. S., Chuvichkina O. V., Zy`kov M. V., Barbarash O. L. Klinicheskaya i prognosticheskaya znachimost` mul`tifokal`nogo ateroskleroza u bol`ny`x s ostry`m koronarny`m sindromom bez pod``ema segmenta ST. Kardiologiya. 2012;52 (7):4–8].
  5.   van den Akker M, Buntinx F, Roos S, Knottnerus JA. Problems in determining occurrence rates of multimorbidity. J Clin Epidemiol. 2001 Jul;54 (7):675–9.
  6.   Goldberg RJ, Currie K, White K, Brieger D, Steg PG, Goodman SG et al. Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Glodal Registry of Acute Coronary Events [GRACE]). Am J Cardiol. 2004 Feb 1;93 (3):288–93.
  7.   Collinson J, Flather MD, Fox KA, Findlay I, Rodrigues E, Dooley P. Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: prospective registry of acute Ischemic syndromes in the UK (PRAISUK). Eur Heart J. 2000 Sep;21 (17):1450–7.
  8.   Cox DA, Stone GW, Grines CL, Stuckey T, Zimetbaum PJ, Tcheng JE et al. Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from CADILLAC trial). Am J Cardiol. 2006 Aug 1;98 (3):331–7.
  9.   Montalescot G, Dallongeville J, Van Belle E, Rouanet S, Baulac C, Degrandsart A, Vicaut E. STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC / ACC definition (the OPERA registry). Eur Heart J. 2007 Jun;28 (12):1409–17.
  10.   Chan MY, Mahaffey KW, Sun LJ, Pieper KS, White HD, Aylward PE et al. Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary disease. JACC Cardiovasc Interv. 2008 Aug;1 (4):369–78.
  11.   Chew DP, Amerena JV, Coverdale SG, Rankin JM, Astley CM, Soman A, Brieger DB. Invasive management and late clinical outcomes in contemporary Australian management of acute coronary syndromes: observations from the ACACIA registry. Med J Aust. 2008 Jun 16;188 (12):691–7.
  12.   Reibis R, Völler H, Gitt A, Jannowitz C, Halle M, Pittrow D, Hildemann S. Management of patients with ST-segment elevation or non-ST-segment elevation acute coronary syndromes in cardiac rehabilitation centers. Clin Cardiol. 2014 Apr;37 (4):213–21.
  13.   Sugiyama T, Hasegawa K, Kobayashi Y, Takahashi O, Fukui T, Tsugawa Y. Differential time trends of outcomes and costs of care for acute myocardial infarction hospitalizations by ST elevation and type of intervention in the United States, 2001–2011. J Am Heart Assoc. 2015 Mar 23;4 (3):e001445.
  14.   Minha S, Gottlieb S, Magalhaes MA, Gavrielov-Yusim N, Krakover R, Goldenberg I et al. Characteristics and management of patients with acute coronary syndrome and normal or non-significant coronary artery disease: results from Acute Coronary Syndrome Israeli Survey (ACSIS) 2004–2010. J Invasive Cardiol. 2014 Aug;26 (8):389–93.
  15.   Lagerqvist В, Husted S, Kontny F, Ståhle E, Swahn E, Wallentin L. 5‑year outcomes in the FRISC–II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study. Lancet. 2006 Sep 16;368 (9540):998–1004 [Lagerqvist V, Husted S, Kontny F, Ståhle E, Swahn E, Wallentin L. 5‑year outcomes in the FRISC–II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study. Lancet. 2006 Sep 16;368 (9540):998–1004].
  16.   Huo Y, Thompson P, Buddhari W, Ge J, Harding S, Ramanathan L et al. Challenges and solutions in medically managed ACS in the Asia-Pacific region: Expert recommendations from the Asia-Pacific ACS Medical Management Working Group. Int J Cardiol. 2015 Mar 15;183:63–75.
  17.   Morrison DA, Sethi G, Sacks J, Henderson WG, Grover F, Sedlis S, Esposito R. Angina with extremely serious operative mortality evaluation. Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients. J Am Coll Cardiol. 2002 Dec 4;40 (11):1951–4.
  18.   Кашталап В. В., Барбараш О. Л. Спорные вопросы ведения пациентов с острым коронарным синдромом без подъема сегмента ST (обзор рекомендаций Европейского кардиологического общества 2015 г.). Русский медицинский журнал. 2015;23 (26):1524–7 [Kashtalap V. V., Barbarash O. L. Sporny`e voprosy` vedeniya paczientov s ostry`m koronarny`m sindromom bez pod``ema segmenta ST (obzor rekomendaczij Evropejskogo kardiologicheskogo obshhestva 2015 g.). Russkij mediczinskij zhurnal. 2015;23 (26):1524–7].
  19.   Grace 2.0 ACS Risk Calculator. Доступно на: http://www.gracescore.org
  20.   Zeymer U, Schneider S, Zahn R, Andresen D. Reported underuse of risk scores in patient with acute coronary syndromes without persistent ST elevations in clinical practice: results of a survey of the ALKK study group. Clin Res Cardiol. 2014 Jan;103 (1):83–4.
  21.   Bajaj RR, Goodman SG, Yan RT, Bagnall AJ, Gyenes G, Welsh RC et al. Treatment and outcomes of patients with suspected acute coronary syndromes in relation to initial diagnostic impressions (insights from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE]). Am J Cardiol. 2013 Jan 15;111 (2):202–7.
  22.   Эрлих А. Д. Первый московский регистр острого коронарного синдрома: результаты 6‑месячного наблюдения. Неотложная кардиология. 2014;2:3–9 [E`rlix A. D. Pervy`j moskovskij registr ostrogo koronarnogo sindroma: rezul`taty` 6‑mesyachnogo nablyudeniya. Neotlozhnaya kardiologiya. 2014;2:3–9].
  23.   Achar SA, Kundu S, Norcross WA. Diagnosis of acute coronary syndrome. Am Fam Physician. 2005 Jul 1;72 (1):119–26.
  24.   Gallagher SM, Lovell MJ, Jones DA, Ferguson E, Ahktar A, Buckhoree Z et al. Does a ‘direct’ transfer protocol reduce time to coronary angiography for patients with non-ST-elevation acute coronary syndromes? A prospective observational study. BMJ Open. 2014 Sep 29;4 (9):e005525.
  25.   Panduranga P, Sulaiman K, Al-Zakwani I, Zubaid M, Rashed W, Al-Mahmeed W et al. Utilization and determinants of in-hospital cardiac catheterization in patients with acute coronary syndrome from the Middle East. Angiology. 2010 Nov;61 (8):744–50.
  26.   Yan AT, Yan RT, Tan M, Huynh T, Soghrati K, Brunner LJ et al. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1‑year outcome. Am Heart J. 2007 Dec;154 (6):1108–15.
  27.   Lee JH, Yang DH, Park HS, Cho Y, Jeong MH, Kim YJ et al. Suboptimal use of evidenced-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value. Am Heart J. 2010 Jun;159 (6):1012–9.
  28.   Al-Zakwani I, Zubaid M, Panduranga P, Rashed W, Sulaiman K, Almahmeed W et al. Medication use pattern and predictors of optimal therapy at discharge in 8176 patients with acute coronary syndrome from 6 Middle Eastern countries: data from the Gulf Registry of acute coronary events. Angiology. 2011 Aug;62 (6):447–54.
  29.   McAlister FA. The end of the risk-treatment paradox? A rising tide lifts all boats. J Am Coll Cardiol. 2011 Oct 18;58 (17):1766–7.
  30.   Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr et al. 2014 AHA / ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: a Report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Dec 23;64 (24):e139–228.
  31.   Amsterdam EA, Peterson ED, Ou FS, Newby LK, Pollack CV, Gibler WB et al. Comparative trends in guidelines adherence among patients with non-ST-segment elevation acute coronary syndromes treated with invasive versus conservative management strategies: Results from the CRUSADE quality improvement initiative. Am Heart J. 2009 Nov;158 (5):748–54.
  32.   Maddox TM, Ho PM, Tsai TT, Wang TY, Li S, Peng SA et al. Clopidogrel use and hospital quality in medically managed patients with non-ST-segment-elevation myocardial infarction. Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5 (4):523–31.
  33.   Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, Yusuf S. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation. 2004 Sep 7;110 (10):1202–8.
  34.   Steinhubl SR, Berger PB, Mann JT3rd, Fry ET, DeLago A, Wilmer C, Topol EJ. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002 Nov 20;288 (19):2411–20.
  35.   Jernberg T, Hasvold P, Henriksson M, Hjelm H, Thuresson M, Janzon M. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of longterm perspective. Eur Heart J. 2015 May 14;36 (19):1163–70.
  36.   Waters DD, Schwartz GG, Olsson AG, Zeiher A, Oliver MF, Ganz P et al. Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a myocardial ischemia reduction with aggressive cholesterol lowering (MIRACL) substudy. Circulation. 2002 Sep 24;106 (13):1690–5.
  37.   Bonaca MP, Bhatt DL, Braunwald E, Cohen M, Steg PG, Storey RF et al. Design and rationale for the prevention of cardiovascular events in patients with prior heart attack using ticagrelor compared to placebo on a background of aspirin-thrombolysis in myocardial infarction 54 (PEGASUS-TIMI 54) trial. Am Heart J. 2014 Apr;167 (4):437–44.e5.
  38.   Peterson PN, Rumsfeld JS, Liang L, Hernandez AF, Peterson ED, Fonarow GC, Masoudi FA. Treatment and risk in heart failure: gaps in evidence or quality? Circ Cardiovasc Qual Outcomes. 2010 May;3 (3):309–15.
  39.   Ko DT, Mamdani M, Alter DA. Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox. JAMA. 2004 Apr 21;291 (15):1864–70.
  40.   Fox CS, Muntner P, Chen AY, Alexander KP, Roe MT, Cannon CP et al. Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry. Circulation. 2010 Jan 26;121 (3):357–65.
  41.   Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007 Nov 15;357 (20):2001–15.
  42.   Шевченко И. И., Эрлих А. Д., Исламов Р. Р., Будяк В. А., Провоторов В. М., Грацианский Н. А. Сравнение данных регистров острых коронарных синдромов РЕКОРД и РЕКОРД-2: лечение и его исходы в стационарах, не имеющих возможности выполнения инвазивных коронарных процедур. Кардиология. 2013;53 (8):4–10 [Shevchenko I. I., E`rlix A. D., Islamov R. R., Budyak V. A., Provotorov V. M., Graczianskij N. A. Sravnenie danny`x registrov ostry`x koronarny`x sindromov REKORD i REKORD-2: lechenie i ego isxody` v staczionarax, ne imeyushhix vozmozhnosti vy`polneniya invazivny`x koronarny`x proczedur. Kardiologiya. 2013;53 (8):4–10].
Barbarash O. L., Kashtalap V. V. Management of patients with non-ST segment elevation acute coronary syndrome. Are all problems solved? Russian Heart Journal. 2016;15 (5):320–326

To access this material please log in or register

Register Authorize
Ru En